These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17191749)

  • 21. Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers.
    Harmer CJ; Heinzen J; O'Sullivan U; Ayres RA; Cowen PJ
    Psychopharmacology (Berl); 2008 Sep; 199(4):495-502. PubMed ID: 18575851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of duloxetine for the treatment of depression: relationship to most recent antidepressant trial.
    Petersen T; Perlis RH; Ticknor C; Lohr J; Solvason HB; O'Reardon JP; Wohlreich MM; Andreotti C; Wilson M; Fava M
    Psychopharmacol Bull; 2008; 41(1):34-45. PubMed ID: 18362869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levomilnacipran (F2695), a norepinephrine-preferring SNRI: profile in vitro and in models of depression and anxiety.
    Auclair AL; Martel JC; Assié MB; Bardin L; Heusler P; Cussac D; Marien M; Newman-Tancredi A; O'Connor JA; Depoortère R
    Neuropharmacology; 2013 Jul; 70():338-47. PubMed ID: 23499664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of duloxetine in medico-legal death investigations in Victoria, Australia (2009-2012).
    Pilgrim JL; Gerostamoulos D; Drummer OH
    Forensic Sci Int; 2014 Jan; 234():165-73. PubMed ID: 24378318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Magnesium Oxide on the Serum Duloxetine Concentration and Antidepressant-Like Effects of Duloxetine in Rats.
    Esumi S; Kitamura Y; Yokota-Kumasaki H; Ushio S; Yamada-Takemoto A; Nagai R; Ogawa A; Kawasaki Y; Sendo T
    Biol Pharm Bull; 2018; 41(11):1727-1731. PubMed ID: 30381673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner.
    Wang SY; Calderon J; Kuo Wang G
    Anesthesiology; 2010 Sep; 113(3):655-65. PubMed ID: 20693878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampus.
    Smith JE; Lakoski JM
    Synapse; 1998 Nov; 30(3):318-28. PubMed ID: 9776135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cymbalta in the treatment of chronic pain syndromes].
    Odinak MM; Kashin AV; Ememlin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):32-4. PubMed ID: 19365388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The safety of duloxetine during pregnancy and lactation.
    Andrade C
    J Clin Psychiatry; 2014 Dec; 75(12):e1423-7. PubMed ID: 25551238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duloxetine Eli Lilly.
    Anttila S; Leinonen E
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1217-21. PubMed ID: 12211418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo.
    Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC
    Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
    Montgomery S
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A first look at duloxetine (Cymbalta) in a postmortem laboratory.
    Anderson D; Reed S; Lintemoot J; Kegler S; DeQuintana S; Sandberg M; Muto J
    J Anal Toxicol; 2006 Oct; 30(8):576-80. PubMed ID: 17132255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.
    Bellantuono C; Marini A; Lucarelli C
    Clin Drug Investig; 2013 Sep; 33(9):685-8. PubMed ID: 23873363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.